Objective: To present efficacy, safety, and bleeding profile results from the clinical trials that supported the U.S. Food and Drug Administration filing for the approval of a single-rod etonogestrel (ENG) contraceptive implant (Implanon).
Design: Integrated analysis of 11 international clinical trials.
Setting: Contraceptive clinics in U.S., Chile, Asia, and Europe.
Patient(s): A total of 942 healthy women, aged 18 to 40 years.
Intervention(s): Insertion of an ENG implant. Most women were enrolled in studies lasting either 2 or 3 years.
Main Outcomes Measure(s): Efficacy was measured by the cumulative Pearl Index in women
Result(s): No pregnancies were reported while the ENG implants were in place. Six pregnancies occurred during the first 14 days after ENG implant removal. Including these six pregnancies, the cumulative Pearl Index was 0.38 (year 1 and 2 Pearl Indexes were 0.27 and 0.30, respectively). Common drug-related adverse events were headache, weight gain, acne, breast tenderness, emotional lability, and abdominal pain. Bleeding pattern changes were observed, but no one pattern predominated.
Conclusion(s): The ENG implant is an efficacious and safe method of contraception which does not require patients' consistent action.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2008.02.140 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Simultaneous removal of impalpable implants in both the left and the right arm - a case report and implications for their use in low-resource settings.
Eur J Contracept Reprod Health Care
October 2024
Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Stellenbosch, Francie van Zyl Dr, Tygerberg Hospital, Bellville, Cape Town, South Africa.
Implanon NXT is a single rod contraceptive implant that is a long-acting reversible contraceptive method. Placement and removal is usually simple if the instructions of use are followed. Deviation from these instructions may lead to the implant becoming impalpable and consequently difficult to remove.
View Article and Find Full Text PDFSite necrosis at the insertion place of the single-rod subdermal contraceptive implant: report of five cases.
Eur J Contracept Reprod Health Care
December 2023
Gynecology Department, Hospital Santojanni, Buenos Aires, Argentina.
Objective: Implant-site necrosis is a rare complication. We present a case-series of a necrosis as an adverse effect after the etonogestrel (ENG)-subdermal contraceptive implant placement.
Material And Methods: Five women with site necrosis after the ENG-implant placement and their clinical manifestations and treatments.
Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case report.
Eur J Contracept Reprod Health Care
June 2022
Department of Obstetrics and Gynecology, Danderyd Hospital, Stockholm, Sweden.
Nexplanon is a single-rod contraceptive implant that should be placed subdermally at the inner side of the upper nondominant arm approximately 8-10 cm above the medial epicondyle of the humerus. Insertion guidelines were recently updated to place of insertion superficial of the triceps muscle to lower risk of insertion into vessels and nerves. If migration however occurs, it is most commonly around the insertion site.
View Article and Find Full Text PDFRemoval of nonpalpable etonogestrel implants after fixation with a curved needle-A case series.
Contraception
November 2021
Department of Reproductive Endocrinology, University Hospital Zurich, Zurich, Switzerland.
Objective: To report our experiences with an extraction technique using a prebent, curved needle placed under deeply located single-rod implants to aid in removal.
Study Design: We conducted a retrospective case series of all patients who were referred for removal of a deeply located or nonpalpable implant to one single specialized center between 2002 and 2019 by screening the database of the private office for "complex implants removals" or "nonpalpable implant" as a result for consultation. After implant-localization via high-resolution ultrasound, we performed a standard incision along the axis of the rod under local anesthesia.
Safety and Benefits of Contraceptives Implants: A Systematic Review.
Pharmaceuticals (Basel)
June 2021
Department of Obstetrics and Gynaecology, "Magna Graecia" University, 88100 Catanzaro, Italy.
Progestin-only contraceptive implants provide long-acting, highly effective reversible contraception. We searched the medical publications in PubMed, CENTRAL, and EMBASE for relevant articles on hormonal implants published in English between 1990 and 2021. Levonorgestrel (LNG) 6-capsule subdermal implants represented the first effective system approved for reversible contraception.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!